I have seen many patients with stomach cancer and have never seen this degree of weight loss, but weight loss is very common ...
Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...
The context of a complex microbiota accelerates the onset and promotes neoplasia in the H. pylori insulin-gastrin mouse model of gastric cancer. The gastric microbiota profile of patients with ...
Leap Therapeutics has come crashing down to earth. The biotech axed plans to advance into phase 3 in gastric cancer on the basis of midstage data, sending its stock down 60% to below $1 ...
Clinical outcomes and changes in body composition following endoscopic submucosal dissection versus total gastrectomy in patients with proximal early gastric cancer. Comparison between neoadjuvant ...
Phase II study of neoadjuvant NALIRIFOX followed by chemoradiation with paclitaxel and carboplatin in locally advanced gastroesophageal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
EPA’s communications with the public have almost dropped off entirely as the new Trump administration takes charge of the agency. On Inauguration Day, EPA’s public affairs office told staff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback